# Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

> **NCT00738452** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** high performance liquid chromatography
- **OTHER:** pharmacological study
- **PROCEDURE:** radionuclide imaging
- **PROCEDURE:** single photon emission computed tomography
- **RADIATION:** radiation therapy
- **RADIATION:** yttrium Y 90 anti-CEA monoclonal antibody cT84.66

## Key facts

- **NCT ID:** NCT00738452
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-06
- **Primary completion:** 2018-02-07
- **Final completion:** 2018-02-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738452, "Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00738452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*